News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Articles|October 2, 2017

Take the CURE Magazine Survey

Author(s)Staff

Thank you for answering the questions below.

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
myelofibrosis

Early Data Show INCA033989 Activity in Calreticulin-Driven Myelofibrosis

BySpencer Feldman
December 31st 2025
Blood cells.

Rusfertide Maintains Hematocrit Control in Patients With Polycythemia Vera

BySilas Inman
December 31st 2025
Image of ribbon.

Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast Cancer

ByKristi Rosa
December 30th 2025
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!

Reading the Fine Print: Why Ingredient Awareness Matters After Cancer

ByBonnie Annis
December 30th 2025
Image of woman.

Stigmas Faced by Patients With Lung Cancer

ByAlex Biese
December 30th 2025
Advertisement
Advertisement

Trending on CURE

1

Gedatolisib Plus Faslodex Shows Efficacy in Advanced HR+ Breast Cancer

2

Reading the Fine Print: Why Ingredient Awareness Matters After Cancer

3

Stigmas Faced by Patients With Lung Cancer

4

Addressing Concerns on Diet During Breast Cancer Treatment

5

Piqray Plus Faslodex Improves PFS in Advanced Breast Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.